Non-profit research Target Usona Institute as a strategic partner for clinical trial support and research services in psychedelic-assisted therapies, highlighting potential collaboration on psilocybin and related compounds for major depressive disorder and anxiety disorders.

Clinical trial growth Leverage their ongoing and upcoming Phase 3 trials to propose specialized contract research, site management, data analytics, and patient recruitment services to accelerate trial timelines and improve study efficiency.

Sustainability focus Position sustainability and responsible research practices as a value proposition to align with their AIA Wisconsin recognition and grant funding interests, offering sustainable lab operations, green procurement, and impact reporting services.

Expanded therapeutic scope Explore opportunities around methylone and PTSD research collaborations or support for multi-indication studies, presenting a broader portfolio of study design, regulatory consulting, and safety monitoring services.

Tech-enabled outreach Propose digital strategy, data governance, and CRO tech stack enhancements (SEO, analytics, patient engagement platforms) to improve trial visibility, enrollment pace, and regulatory documentation quality for their psychopharmacology programs.